Because there is currently no detailed information regarding 3D molecular interactions between these coumarins and BACE1 and AChE, we performed molecular docking analyses and detailed enzyme kinetic analysis to investigate the potential of coumarins as potent anti-AD drug candidates. This evidence concerns the gene BACE1 and Alzheimer disease.